Immune cell regulation of glia during CNS injury and disease

AD Greenhalgh, S David, FC Bennett - Nature Reviews Neuroscience, 2020‏ - nature.com
Glial cells are abundant in the CNS and are essential for brain development and
homeostasis. These cells also regulate tissue recovery after injury and their dysfunction is a …

Gene therapy for neurological disorders: progress and prospects

BE Deverman, BM Ravina, KS Bankiewicz… - Nature Reviews Drug …, 2018‏ - nature.com
Adeno-associated viral (AAV) vectors are a rapidly emerging gene therapy platform for the
treatment of neurological diseases. In preclinical studies, transgenes encoding therapeutic …

Protective functions of reactive astrocytes following central nervous system insult

M Linnerbauer, V Rothhammer - Frontiers in immunology, 2020‏ - frontiersin.org
Astrocytes play important roles in numerous central nervous system disorders including
autoimmune inflammatory, hypoxic, and degenerative diseases such as Multiple Sclerosis …

Adeno-associated virus technologies and methods for targeted neuronal manipulation

L Haery, BE Deverman, KS Matho, A Cetin… - Frontiers in …, 2019‏ - frontiersin.org
Cell-type-specific expression of molecular tools and sensors is critical to construct circuit
diagrams and to investigate the activity and function of neurons within the nervous system …

Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte–neuron communication

C Frühbeis, D Fröhlich, WP Kuo, J Amphornrat… - PLoS …, 2013‏ - journals.plos.org
Reciprocal interactions between neurons and oligodendrocytes are not only crucial for
myelination, but also for long-term survival of axons. Degeneration of axons occurs in …

Adeno-associated virus-based gene therapy for CNS diseases

M Hocquemiller, L Giersch, M Audrain… - Human gene …, 2016‏ - liebertpub.com
Gene therapy is at the cusp of a revolution for treating a large spectrum of CNS disorders by
providing a durable therapeutic protein via a single administration. Adeno-associated virus …

Gene therapy tools for brain diseases

S Ingusci, G Verlengia, M Soukupova… - Frontiers in …, 2019‏ - frontiersin.org
Neurological disorders affecting the central nervous system (CNS) are still incompletely
understood. Many of these disorders lack a cure and are seeking more specific and effective …

Progresses towards safe and efficient gene therapy vectors

S Chira, CS Jackson, I Oprea, F Ozturk… - …, 2015‏ - pmc.ncbi.nlm.nih.gov
The emergence of genetic engineering at the beginning of the 1970′ s opened the era of
biomedical technologies, which aims to improve human health using genetic manipulation …

CNS myelination requires VAMP2/3-mediated membrane expansion in oligodendrocytes

M Lam, K Takeo, RG Almeida, MH Cooper… - Nature …, 2022‏ - nature.com
Myelin is required for rapid nerve signaling and is emerging as a key driver of CNS plasticity
and disease. How myelin is built and remodeled remains a fundamental question of …

Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer's mice

A Ittner, SW Chua, J Bertz, A Volkerling… - Science, 2016‏ - science.org
Amyloid-β (Aβ) toxicity in Alzheimer's disease (AD) is considered to be mediated by
phosphorylated tau protein. In contrast, we found that, at least in early disease, site-specific …